Astarte Medical's software solution, NICUtrition, will revolutionize the care of preterm infants by providing quantitative data about gut health, allowing for personalized care and nutrition to optimize growth and outcomes.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 11/05/18 | undisclosed |
Next Act Fund | undisclosed | |
| 05/07/19 | $5,000,000 | Series A |
Keiretsu Capital Fund Keiretsu Forum Mid Atlantic Lunsford Capital Next Act Fund OCA Ventures Viking Global Investors Wing Venture Capital | undisclosed |
